Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review

The therapeutic value of immune checkpoint inhibitors (ICIs) in a variety of tumors has been found and recognized, and although ICIs have improved the prognosis of many patients with advanced tumors, these drugs sometimes cause immune-related adverse events (irAEs). PATIENT CONCERNS: We report a 67-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Loulu, Li, Xuemei, Guo, Zhijun, Tang, Lin, Peng, Jieqiong, Liu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750698/
https://www.ncbi.nlm.nih.gov/pubmed/36626474
http://dx.doi.org/10.1097/MD.0000000000032240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750698/
https://www.ncbi.nlm.nih.gov/pubmed/36626474
http://dx.doi.org/10.1097/MD.0000000000032240

Ejemplares similares